| 000 | 01580 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518084914.0 | ||
| 264 | 0 | _c20200720 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a2058-5276 | ||
| 024 | 7 |
_a10.1038/s41564-019-0634-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPetrovic Fabijan, Aleksandra | |
| 245 | 0 | 0 |
_aSafety of bacteriophage therapy in severe Staphylococcus aureus infection. _h[electronic resource] |
| 260 |
_bNature microbiology _c03 2020 |
||
| 300 |
_a465-472 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAustralia |
| 650 | 0 | 4 | _aBacteriophages |
| 650 | 0 | 4 |
_aDNA, Bacterial _xblood |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 |
_aEndocarditis _xmicrobiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMyoviridae |
| 650 | 0 | 4 |
_aPhage Therapy _xadverse effects |
| 650 | 0 | 4 |
_aShock, Septic _xmicrobiology |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xtherapy |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xvirology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aLin, Ruby C Y | |
| 700 | 1 | _aHo, Josephine | |
| 700 | 1 | _aMaddocks, Susan | |
| 700 | 1 | _aBen Zakour, Nouri L | |
| 700 | 1 | _aIredell, Jonathan R | |
| 773 | 0 |
_tNature microbiology _gvol. 5 _gno. 3 _gp. 465-472 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41564-019-0634-z _zAvailable from publisher's website |
| 999 |
_c30643295 _d30643295 |
||